A Trial of Validation and Restoration of Immune Dysfunction in Severe Infections and Sepsis

NCT03332225 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Sepsis
Macrophage Activation Syndrome

Interventions

DRUG: Anakinra
DRUG: Recombinant human interferon-gamma
DRUG: Placebo

Sponsor

Hellenic Institute for the Study of Sepsis